Today: 8 November 2025
Subscribe
Conduent (CNDT) Q3 2025 Earnings: Revenue Misses at $767M as Adjusted EBITDA Margin Climbs to 5.2%; FY 2025 Margin Outlook 5.0%–5.5%, Shares Slide
 ·  ·  ·  ·  · 

Conduent (CNDT) Q3 2025 Earnings: Revenue Misses at $767M as Adjusted EBITDA Margin Climbs to 5.2%; FY 2025 Margin Outlook 5.0%–5.5%, Shares Slide

by
8 November 2025

Conduent Incorporated (NASDAQ: CNDT) reported third‑quarter 2025 revenue of $767 million (down 5% YoY) and Adjusted EBITDA of $40 million with a 5.2% margin, reflecting continued cost discipline even as top‑line pressure persisted. Management reiterated a full‑year 2025 Adjusted EBITDA margin outlook of 5.0%–5.5% alongside Adjusted Revenue guidance of $3.05–$3.10 billion. The stock fell sharply following the release. [1]

Key takeaways (Nov. 8, 2025)

  • Margins improving: Adjusted EBITDA rose to $40M (+25% YoY), with the margin at 5.2% (+110 bps YoY). [2]
  • Outlook intact on profitability: Management maintained FY25 Adjusted EBITDA margin guidance of 5.0%–5.5%; Adjusted Revenue guided to $3.05B–$3.10B. [3]
  • Strategic moves continue: Conduent completed a credit facility refinancing, repurchased ~4.7M shares, and highlighted AI‑driven product updates and new contracts. [4]

By the numbers

  • Revenue:$767M (Adjusted Revenue also $767M, –1.8% YoY on an adjusted basis).
  • Adjusted EBITDA / Margin:$40M / 5.2%.
  • New business signings (ACV):$111M; Net ARR (TTM):$25M.
  • Cash & Liquidity (quarter‑end):$264M cash; $198M unused under revolver; Net adjusted leverage 3.2x; Capex 3.8% of revenue.
  • 2025 “exit rate” target:~8% Adjusted EBITDA margin. [5]

What moved the stock on earnings day

Shares fell double digits Friday after the revenue miss and cautious top‑line outlook, despite better profitability trends. Coverage across market outlets flagged the gap between margin progress and revenue pressure, with some noting weak cash flow in the quarter. [6]

The Associated Press snapshot also highlighted the loss of $46M (GAAP) and revenue shortfall versus Street expectations, underscoring investor concerns around growth. [7]

Segment performance and operational context

  • Transportation remained a bright spot, with Adjusted Revenue up ~14.9% YoY to $162M, helped by equipment sales and net ramp activity.
  • Commercial ($367M, –4.7% YoY) and Government ($238M, –6.7% YoY) declined on lower volumes and prior contract losses, partially offset by new business and cost actions. [8]

Strategy watch: AI, government wins, and footprint expansion

Management pointed to several milestones meant to stabilize growth and lift margins:

  • AI in government solutions to improve benefit disbursements and fraud prevention.
  • Refinanced revolving credit facility (maturity extension) and payoff of Term Loan A.
  • Richmond Metropolitan Transportation Authority contract to implement Pay‑by‑Plate tolling.
  • Philippines CXM expansion (Lipa‑Malvar facility) for a U.S. healthcare client.
  • FastCap® Finance Analytics enhanced with GenAI‑powered contract/spend analytics.
  • Maven® disease surveillance deployed for the State of Delaware. [9]

Management also said ~87% of the $1B capital allocation target has been executed, with plans to exceed that goal—part of a broader portfolio rationalization and liquidity focus. [10]

Guidance check (as of Nov. 8)

  • FY 2025 Adjusted Revenue:$3.05B–$3.10B
  • FY 2025 Adjusted EBITDA margin:5.0%–5.5%
  • 2025 exit rate (mid‑term view):~8% Adjusted EBITDA margin if execution continues. [11]

Today’s coverage & commentary (Nov. 8, 2025)

  • GuruFocus emphasized that Conduent met guidance on adjusted revenue and EBITDA margin, while noting progress toward a $1B capital allocation goal and continued AI integration. [12]
  • TipRanks highlighted EPS and revenue misses and the ensuing stock decline. [13]
  • Investing.com recapped the revenue miss vs. consensus and noted recent share performance. [14]
  • Chartmill & MLQ.ai framed the market reaction as a sharp sell‑off despite margin improvement and debt refinancing. [15]
  • Meyka published a Saturday brief flagging post‑earnings trading interest around CNDT. (Note: third‑party pricing/volume snapshots can vary by timestamp and source.) [16]

Why it matters

Conduent’s quarter reiterates a familiar pattern: cost and efficiency actions are lifting margins, but top‑line drag—especially in Commercial and Government—continues to weigh on sentiment. The Transportation upswing and AI‑driven product moves help, yet investors will likely want to see sustained ARR growth, steadier free cash flow, and contract wins that translate into organic revenue expansion before re‑rating the shares. [17]

What to watch next

  1. Sales pipeline conversion and ARR growth: does Transportation strength carry into 2026, and can Commercial/Government stabilize? [18]
  2. Cash flow trajectory and balance‑sheet flexibility after the refinancing. [19]
  3. Execution on AI initiatives in Government and enterprise clients—evidence that efficiency gains translate into new revenue. [20]

Quick reference (Q3 2025 vs. Q3 2024)

  • Revenue:$767M vs. $807M
  • Adjusted Revenue:$767M vs. $781M
  • Adjusted EBITDA:$40M vs. $32M
  • Adjusted EBITDA Margin:5.2% vs. 4.1%
  • GAAP Net Income (Loss):$(46)M vs. $123M (prior‑year benefited from divestiture gains) [21]

Editor’s note on sources (Nov. 8, 2025)

Figures and outlooks are taken from Conduent’s official Q3 2025 press release and investor materials, with additional corroboration from mainstream financial outlets and market coverage published on Nov. 7–8, 2025. [22]

This article is for informational purposes only and is not investment advice.

Conduent CNDT Q2 2025 Earnings Call
Watch this video on YouTube.

References

1. www.globenewswire.com, 2. www.globenewswire.com, 3. www.news.conduent.com, 4. www.news.conduent.com, 5. www.marketscreener.com, 6. mlq.ai, 7. www.ctinsider.com, 8. www.marketscreener.com, 9. www.news.conduent.com, 10. www.globenewswire.com, 11. www.news.conduent.com, 12. www.gurufocus.com, 13. www.tipranks.com, 14. ca.investing.com, 15. www.chartmill.com, 16. meyka.com, 17. www.marketscreener.com, 18. www.marketscreener.com, 19. www.news.conduent.com, 20. www.news.conduent.com, 21. www.globenewswire.com, 22. www.news.conduent.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)
  2. Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)
  3. EOSE News Today (Nov 8, 2025): Analyst Downgrade Caps Volatile Week After Record Q3; Warrants Jump as New Orders Build
  4. Today in Airline Routes (Nov. 8, 2025): Breeze enters Twin Falls; JetBlue targets Destin–Fort Walton; Spirit lands in Key West — plus key global moves

Stock Market Today

  • FuboTV's Hulu + Live TV Merger and Channel Store Launch Reshape Its Investment Narrative
    November 8, 2025, 12:58 PM EST. FuboTV's completion of the Hulu + Live TV merger positions the company as one of the largest live-TV platforms in North America, while the Fubo Channel Store adds premium standalone content and hundreds of FAST channels to drive engagement. With the company reporting back-to-back quarters of positive adjusted EBITDA, investors are weighing a more favorable profitability path against ongoing cash burn and negative free cash flow. The Channel Store could lift ARPU and retention by bundling content, but the long-term growth story remains tied to scale, content partnerships, and operating efficiency. Analysts' forecasts for revenue and earnings imply a path to profitability, though valuation uncertainty and questions about sustained cash flow persist.
  • Week in Review: Nasdaq's Worst Week Since April, Three Trades and Earnings
    November 8, 2025, 12:56 PM EST. Nasdaq posts its worst week since April, down about 3%, with the S&P 500 off 1.6%. Investors fret over eye-watering AI valuations as Nvidia tumbled, erasing its $5 trillion market-cap halo amid China reopening doubts. A government shutdown hangover compounds the pullback, with October job cuts at a 22-year high and a weak University of Michigan sentiment reading underscoring softening demand. In response, the Investing Club executed three trades: adding to Starbucks on a perceived overreaction to consumer fears and a bright long-term turnaround story under Brian Niccol; boosting Boeing after a flawed quarter presented a buying opportunity; and others discussed amid a volatile tape. The stance remains: own the winners, don't trade, as data and policy swirl.
  • Evercore ISI Raises Gen Digital Price Target, Signaling Upbeat GEN Outlook
    November 8, 2025, 12:54 PM EST. Evercore ISI boosted Gen Digital's price objective from $35.00 to $37.00 and reiterated an outperform rating, implying about 46.97% upside from the prior close. The note comes as other firms issue fresh views: B. Riley initiated coverage with a Buy rating and a $46 target; Barclays, Wells Fargo, RBC, and Jefferies issued varied calls (targets ranging from the low to mid $40s with ratings from equal weight to hold). Market consensus from MarketBeat skewed to a Moderate Buy with an average target of about $36. Gen Digital traded around $25.18, down 1.1% on the session, with a robust quarter: EPS $0.62 vs $0.61 est, revenue $1.22B vs $1.20B estimate, and strong YoY growth of 25.3%. FY/Q3 2026 guidance sits at $2.51-$2.56 and $0.62-$0.64 respectively.
  • Evercore ISI Cuts Doximity Target to $70; Mixed Analyst Views on DOCS
    November 8, 2025, 12:53 PM EST. Evercore ISI cut Doximity's target price from $81 to $70, while maintaining an outperform rating, implying about a 29.89% upside from current levels. The call follows a chorus of mixed analyst views on DOCS: Wells Fargo lifted its target to $62 with an equal weight stance; Goldman Sachs issued a $64 target with a sell rating; Raymond James set a $75 target with a buy stance; Zacks moved to hold; Truist raised its objective to $61 and rated it hold. Friday data show DOCS trading near the low-$50s (around $53.89) on heavier volume, with the stock near its 50-day moving average and above the 200-day moving average. An insider sale added another wrinkle to the week's news.
  • Barclays Lifts Datadog Price Target to $215 as Analysts Turn Bullish on DDOG
    November 8, 2025, 12:51 PM EST. Barclays raised its price target for Datadog (DDOG) from $170 to $215, signaling a potential upside of about 16%. The firm maintains an overweight rating as part of a broader raft of positive research on the cloud-monitoring play. Other analysts chimed in: Jefferies lifted their target to $220 with a Buy rating; Oppenheimer moved to $195 with an Outperform; TD Cowen lifted to $180 with a Buy; Wells Fargo initiated coverage at an Overweight with a $190 objective; Stifel set $205. Market data show a mixed tape for DDOG, with the stock around $185 after a mid-day move, and a robust 1-year rally. Datadog posted solid quarterly results, beating consensus on EPS and revenue, and guiding for 2025 with EPS around $2.00.
Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026
Previous Story

Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

SPY Holds the $667 Line as AI CapEx Booms and Fed Officials Cloud a December Cut — Weekend Market Wrap (Nov. 8, 2025)
Next Story

SPY Holds the $667 Line as AI CapEx Booms and Fed Officials Cloud a December Cut — Weekend Market Wrap (Nov. 8, 2025)

Related Articles

Go toTop